Future landscape for the management of membranous nephropathy
Amongall glomerular diseases, membranous nephropathy (MN) is perhaps the one in which major progress has been made in recent decades, in both the understanding of the pathogenesis and treatment. Despite the overall significant response rates to these therapies—particularly rituximab and cyclical reg...
-д хадгалсан:
| Үндсэн зохиолч: | |
|---|---|
| Бусад зохиолчид: | , |
| Формат: | article |
| Хэл сонгох: | англи |
| Хэвлэсэн: |
2023
|
| Нөхцлүүд: | |
| Онлайн хандалт: | https://hdl.handle.net/20.500.12008/52238 |
| Шошгууд: |
Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!
|